Write a review.

Mira Life Science Ventures

Privately held; Founded in 2020
1 - 5 employees

1 followers

Notes

Relationship history

  • Reminders

    No reminders

  • Notes

    No notes

  • Follow

Other requests for proposal

There are no other requests for proposal from Mira Life Science Ventures

Investor profile

An new alternative to traditional venture investment into early-stage life science innovation - Highly flexible corporate structure with broad investment capabilities, no restrictions. Can invest in companies, in-license patents, incubate technology, innovate, and collect royalties – a compelling alternative to traditional venture funds and private equity - Broad and diverse access to opportunities - Highly experienced management team- long history of product invention and development - Investor/Shareholder focused while providing “Evergreen” returns - Management does not take a guaranteed 2% management fee or a 20% carry, off-the-top, on revenues before investor/shareholder distributions - Previous Fund Management experience: 13 years, 22% IRR, 80x return on original capital


Investor type

Investing as asset owner (own investment)


Investment interests

Asset class

Private capital


Investment vehicle

  • Pooled investments
  • Foundations
  • Investment club
  • Direct investments
  • Miscellaneous direct investments
  • Segregated/managed accounts
  • Structured products
  • Investment products
  • Leverage products
  • Derivatives (non-structured products)
  • Options
  • Other investment vehicles


Investment region

  • Global
  • Global diversified markets
  • Global diversified
  • Global developed markets
  • Global developed markets diversified
  • Global emerging markets
  • Global emerging markets (diversified)
  • Global frontier markets
  • Global non-classified markets
  • Europe
  • Developed European countries
  • Europe diversified
  • European diversified markets
  • Europe diversified
  • Frontier European countries
  • Frontier European countries diversified
  • Emerging European countries
  • Emerging European countries diversified
  • Non-classified European countries
  • Asia
  • Diversified Asian markets
  • Developed Asian countries
  • Emerging Asian countries
  • Frontier Asian countries
  • Non-classified Asian countries
  • MENA
  • Diversified MENA Markets
  • Developed MENA countries
  • Frontier MENA countries
  • Emerging MENA countries
  • Non-classified MENA countries
  • Australia and Oceania
  • APAC developed markets
  • APAC diversified markets
  • APAC non-classified markets
  • North America
  • Developed Northern American countries
  • Diversified Northern American markets
  • Emerging Northern American countries
  • Non-classified Northern American countries
  • South America
  • Diversified Southern American markets
  • Emerging Southern American countries
  • Frontier Southern American countries
  • Non-classified Southern American countries
  • Sub-Saharan Africa
  • Emerging Sub-Saharan countries
  • Diversified Sub-Saharan markets
  • Frontier Sub-Saharan countries
  • Non-classified Sub-Saharan countries
  • Central America and the Caribbean
  • Diversified CAC countries
  • Emerging CAC countries
  • Frontier CAC countries
  • Non-classified CAC countries


Investment focus

  • Not relevant/no specific focus
  • Sustainable Investing
  • Negative Screening (SRI Exclusion Criteria)
  • Impact Investment
  • Medical Research
  • Cancer research
  • Diabetes research
  • Miscellaneous medical research
  • Employment Generation
  • Access to Basic Services
  • Health
  • Access to Finance
  • Sustainable Consumer Products
  • Green Technology/Cleantech
  • Environmental Markets and Sustainable Real Assets
  • Thematic Investments
  • Strategy (Outcome-Oriented)
  • Risk-Based
  • Return-Based
  • Efficient Portfolios
  • Underlying Company Focus
  • Market Cap Focus
  • Quality Factors
  • Enhanced Indexing
  • Dynamic Indexing


Investment process

  • Not applicable/relevant
  • Active investments
  • Active selection
  • Active with management activities
  • Passive investments
  • Synthetic Replication
  • Physical Replication


Trading/liquidity type

  • Off-exchange traded
  • Primary market
  • Direct search market/Private trading
  • Private placements
  • Exchange traded
  • Not relevant
  • Not relevant


Required investment set-up


Selected dividend policy should be

Reinvesting, Distributing


Tax reporting

United Kingdom, United States

Considered legal/investment requirements

The investment should be available for

Qualified/accredited investor from: Switzerland, Germany, France, United Kingdom, United States, Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, South Africa, Spain, Sweden, Türkiye, Ukraine, United Arab Emirates NonQualified/retail investor from: Switzerland, Germany, France, United Kingdom, United States, Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, South Africa, Spain, Sweden, Türkiye, Ukraine, United Arab Emirates


Retrocessions

Both possible


Team